Added to YB: 2025-06-27
Pitch date: 2025-06-26
CLPT [bullish]
ClearPoint Neuro, Inc.
+5.65%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.
Market Cap
$438.6M
Pitch Price
$12.03
Price Target
N/A
Dividend
N/A
EV/EBITDA
-20.80
P/E
-18.67
EV/Sales
12.70
Sector
Health Care Equipment and Supplies
Category
special_situation
ClearPoint Neuro Set to Benefit from Rare Disease Regulatory Revolution
CLPT added: Top pick in biotech due to FDA fast-tracking rare disease approvals, accelerating partner timelines. Reduced binary risk - like owning rare disease biotech ETF in one stock. Biotech assets priced for zero upside despite trials progressing in favorable FDA environment.
Read full article (1 min)